ASML shares fell after proposed U.S. export restrictions targeted the Dutch lithography equipment maker's exposure to an already fragile Chinese market.

The stock decline followed reports that Washington is preparing new export control measures aimed at further limiting semiconductor manufacturing equipment sales to China. The proposed curbs would add pressure on a market segment that ASML had already flagged as weakened.

China has been a major revenue source for ASML, the world's dominant supplier of lithography machines used to produce advanced chips. Any tightening of export rules therefore carries direct commercial consequences for the Veldhoven-based company.

Why does the stock reaction matter?

Investors treat export-control news as a leading indicator of ASML's order pipeline. When Washington signals new restrictions, customers in China often accelerate, delay or cancel purchases of lithography systems, and the share price adjusts before any orders are formally lost.

The selloff also reflects the broader environment for semiconductor equipment suppliers, who have spent the past two years absorbing successive rounds of U.S. and allied export controls on chipmaking tools destined for China.

What do the proposed curbs target?

The measures under consideration in the United States aim to restrict additional categories of chipmaking equipment and related technology sales to Chinese customers. For ASML, this compounds existing Dutch and American restrictions that already limit its ability to ship its most advanced machines to China.

Analysts and market participants have repeatedly noted that China demand for semiconductor equipment was already under strain before this latest proposal, according to CNBC's reporting on the share move.

What comes next?

The proposed measures are not yet final. ASML, its customers and industry observers will watch for formal publication of the rules and for any response from the Dutch government, which must coordinate its own export policy with U.S. restrictions.

Until the rules are enacted, uncertainty itself carries a cost: Chinese buyers may hesitate to place orders, and ASML's guidance for the region becomes harder to model. The share price decline captures exactly that risk.